These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26608082)

  • 1. Developmental Expression of CYP2B6: A Comprehensive Analysis of mRNA Expression, Protein Content and Bupropion Hydroxylase Activity and the Impact of Genetic Variation.
    Pearce RE; Gaedigk R; Twist GP; Dai H; Riffel AK; Leeder JS; Gaedigk A
    Drug Metab Dispos; 2016 Jul; 44(7):948-58. PubMed ID: 26608082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetic determinants of interindividual variability in bupropion hydroxylation by cytochrome P450 2B6 in human liver microsomes.
    Hesse LM; He P; Krishnaswamy S; Hao Q; Hogan K; von Moltke LL; Greenblatt DJ; Court MH
    Pharmacogenetics; 2004 Apr; 14(4):225-38. PubMed ID: 15083067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of sex, ethnicity, and CYP2B6 genotype on bupropion metabolism as an index of hepatic CYP2B6 activity in humans.
    Ilic K; Hawke RL; Thirumaran RK; Schuetz EG; Hull JH; Kashuba AD; Stewart PW; Lindley CM; Chen ML
    Drug Metab Dispos; 2013 Mar; 41(3):575-81. PubMed ID: 23238783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the CYP2B6*6 allele on catalytic properties and inhibition of CYP2B6 in vitro: implication for the mechanism of reduced efavirenz metabolism and other CYP2B6 substrates in vivo.
    Xu C; Ogburn ET; Guo Y; Desta Z
    Drug Metab Dispos; 2012 Apr; 40(4):717-25. PubMed ID: 22232427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective Bupropion Hydroxylation by Cytochrome P450 CYP2B6 and Cytochrome P450 Oxidoreductase Genetic Variants.
    Wang PF; Neiner A; Kharasch ED
    Drug Metab Dispos; 2020 Jun; 48(6):438-445. PubMed ID: 32238417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression.
    Lamba V; Lamba J; Yasuda K; Strom S; Davila J; Hancock ML; Fackenthal JD; Rogan PK; Ring B; Wrighton SA; Schuetz EG
    J Pharmacol Exp Ther; 2003 Dec; 307(3):906-22. PubMed ID: 14551287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The P450 oxidoreductase (POR) rs2868177 and cytochrome P450 (CYP) 2B6*6 polymorphisms contribute to the interindividual variability in human CYP2B6 activity.
    Gao LC; Liu FQ; Yang L; Cheng L; Dai HY; Tao R; Cao SP; Wang D; Tang J
    Eur J Clin Pharmacol; 2016 Oct; 72(10):1205-1213. PubMed ID: 27439448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing midazolam hydroxylation activity in human liver microsomes.
    He P; Court MH; Greenblatt DJ; von Moltke LL
    Drug Metab Dispos; 2006 Jul; 34(7):1198-207. PubMed ID: 16638818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P-450 2B6 is responsible for interindividual variability of propofol hydroxylation by human liver microsomes.
    Court MH; Duan SX; Hesse LM; Venkatakrishnan K; Greenblatt DJ
    Anesthesiology; 2001 Jan; 94(1):110-9. PubMed ID: 11135730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective metabolism of bupropion by cytochrome P4502B6 (CYP2B6) and human liver microsomes.
    Coles R; Kharasch ED
    Pharm Res; 2008 Jun; 25(6):1405-11. PubMed ID: 18219560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of CYP2B6 polymorphism on hepatic efavirenz metabolism in vitro.
    Desta Z; Saussele T; Ward B; Blievernicht J; Li L; Klein K; Flockhart DA; Zanger UM
    Pharmacogenomics; 2007 Jun; 8(6):547-58. PubMed ID: 17559344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.
    Hesse LM; Venkatakrishnan K; Court MH; von Moltke LL; Duan SX; Shader RI; Greenblatt DJ
    Drug Metab Dispos; 2000 Oct; 28(10):1176-83. PubMed ID: 10997936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity.
    Faucette SR; Hawke RL; Lecluyse EL; Shord SS; Yan B; Laethem RM; Lindley CM
    Drug Metab Dispos; 2000 Oct; 28(10):1222-30. PubMed ID: 10997944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of metabolism dependent inhibition of CYP2B6 mediated bupropion hydroxylation in human liver microsomes by monoamine oxidase inhibitors and prediction of potential as perpetrators of drug interaction.
    Nirogi R; Palacharla RC; Mohammed AR; Manoharan A; Ponnamaneni RK; Bhyrapuneni G
    Chem Biol Interact; 2015 Mar; 230():9-20. PubMed ID: 25656918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Variants of Pregnane X Receptor (PXR) and CYP2B6 Affect the Induction of Bupropion Hydroxylation by Sodium Ferulate.
    Gao L; He Y; Tang J; Yin J; Huang Z; Liu F; Ouyang D; Chen X; Zhang W; Liu Z; Zhou H
    PLoS One; 2013; 8(6):e62489. PubMed ID: 23840296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetic Influence on Stereoselective Steady-State Disposition of Bupropion.
    Kharasch ED; Lenze EJ
    Drug Metab Dispos; 2024 Apr; 52(5):455-466. PubMed ID: 38467432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human hepatic CYP2B6 developmental expression: the impact of age and genotype.
    Croom EL; Stevens JC; Hines RN; Wallace AD; Hodgson E
    Biochem Pharmacol; 2009 Jul; 78(2):184-90. PubMed ID: 19464434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the selected cytochrome P450 oxidoreductase genetic polymorphisms on cytochrome P450 2B6 activity as measured by bupropion hydroxylation.
    Lv J; Hu L; Zhuo W; Zhang C; Zhou H; Fan L
    Pharmacogenet Genomics; 2016 Feb; 26(2):80-7. PubMed ID: 26580670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human CYP2B6-catalyzed bupropion hydroxylation by Ginkgo biloba extract: effect of terpene trilactones and flavonols.
    Lau AJ; Chang TK
    Drug Metab Dispos; 2009 Sep; 37(9):1931-7. PubMed ID: 19487249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of CYP2B6*6 and CYP2C19*2 genotype on chlorpyrifos metabolism.
    Crane AL; Klein K; Zanger UM; Olson JR
    Toxicology; 2012 Mar; 293(1-3):115-122. PubMed ID: 22281205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.